AWM Investment Company’s Chemomab Therapeutics CMMB Stock Holding History

AWM Investment Company’s Portfolio CMMB Stock Details CMMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,471	Closed	-$217K	–	88
2020 Q2	$217K	Hold	2,471	–	–	0.04%	85
2020 Q1	$124K	Sell	2,471 -2,419	-49%	-$177K	0.03%	79
2019 Q4	$438K	Buy	+4,890	New	+$592K	0.09%	77
2019 Q3	–	Sell	-1,563	Closed	-$448K	–	90
2019 Q2	$448K	Hold	1,563	–	–	0.09%	84
2019 Q1	$679K	Buy	+1,563	New	+$790K	0.13%	77

Other funds holding CMMB

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

RegentAtlantic Capital Morristown, New Jersey $3.34B AUM 14.54% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AWM Investment Company's CMMB Position: Q3 2020 in Review

AWM Investment Company sold out of Chemomab Therapeutics (CMMB) in Q3 2020, closing a stake of 2,471 shares — an estimated $217K sold.

AWM Investment Company first reported a position in CMMB in Q1 2019 and held it in 5 quarters. The position peaked at $679K in Q1 2019. 6 funds tracked by Wall St. Rank hold CMMB as of Q3 2020.

AWM Investment Company reported no remaining Chemomab Therapeutics position as of Q3 2020 after selling out during the quarter.
AWM Investment Company sold 2,471 Chemomab Therapeutics shares in Q3 2020, an estimated $217K.
AWM Investment Company first reported a position in Chemomab Therapeutics in Q1 2019 and held it in 5 quarters.
AWM Investment Company's Chemomab Therapeutics position peaked at $679K in Q1 2019.
6 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q3 2020.

Based on AWM Investment Company's 13F filing for Q3 2020, filed 13 Nov 2020.